{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:50:11Z","timestamp":1771339811543,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T00:00:00Z","timestamp":1358726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/aps.2012.164","type":"journal-article","created":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T11:37:22Z","timestamp":1358768242000},"page":"352-359","source":"Crossref","is-referenced-by-count":46,"title":["Apocynin attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction in mice"],"prefix":"10.1038","volume":"34","author":[{"given":"Yu-qiong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-jie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-li","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-jin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding-liang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-quan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,21]]},"reference":[{"key":"BFaps2012164_CR1","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/hc1102.105289","volume":"105","author":"MR Zile","year":"2002","unstructured":"Zile MR, Brutsaert DL . New concepts in diastolic dysfunction and diastolic heart failure: part I. Circulation 2002; 105: 1387\u201393.","journal-title":"Circulation"},{"key":"BFaps2012164_CR2","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1161\/01.HYP.0000128621.68160.dd","volume":"43","author":"Y Matsui","year":"2004","unstructured":"Matsui Y, Jia N, Okamoto H, Kon S, Onozuka H, Akino M, et al. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension 2004; 43: 1195\u2013201.","journal-title":"Hypertension"},{"key":"BFaps2012164_CR3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1172\/JCI200524408","volume":"115","author":"FJ Giordano","year":"2005","unstructured":"Giordano FJ . Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005; 115: 500\u20138.","journal-title":"J Clin Invest"},{"key":"BFaps2012164_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s11906-010-0103-9","volume":"12","author":"AR Weseler","year":"2010","unstructured":"Weseler AR, Bast A . Oxidative stress and vascular function: implications for pharmacologic treatments. Curr Hypertens Rep 2010; 12: 154\u201361.","journal-title":"Curr Hypertens Rep"},{"key":"BFaps2012164_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/01.HYP.33.2.663","volume":"33","author":"K Singh","year":"1999","unstructured":"Singh K, Sirokman G, Communal C, Robinson KG, Conrad CH, Brooks WW, et al. Myocardial osteopontin expression coincides with the development of heart failure. Hypertension 1999; 33: 663\u201370.","journal-title":"Hypertension"},{"key":"BFaps2012164_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1755-5922.2010.00243.x","volume":"30","author":"N Jia","year":"2012","unstructured":"Jia N, Dong P, Ye Y, Qian C, Dai Q . Allopurinol attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction. Cardiovasc Ther 2012; 30: 117\u201323.","journal-title":"Cardiovasc Ther"},{"key":"BFaps2012164_CR7","first-page":"H1057","volume":"260","author":"C Ceconi","year":"1991","unstructured":"Ceconi C, Cargnoni A, Pasini E, Condorelli E, Curello S, Ferrari R . Evaluation of phospholipid peroxidation as malondialdehyde during myocardial ischemia and reperfusion injury. Am J Physiol 1991; 260: H1057\u201361.","journal-title":"Am J Physiol"},{"key":"BFaps2012164_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/FJC.0b013e318033dfd4","volume":"49","author":"T Nishioka","year":"2007","unstructured":"Nishioka T, Suzuki M, Onishi K, Takakura N, Inada H, Yoshida T, et al. Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone\u2013mediated inflammation. J Cardiovasc Pharmacol 2007; 49: 261\u20138.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFaps2012164_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00004872-200403000-00016","volume":"22","author":"A Virdis","year":"2004","unstructured":"Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL . Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 2004; 22: 535.","journal-title":"J Hypertens"},{"key":"BFaps2012164_CR10","doi-asserted-by":"publisher","first-page":"R1858","DOI":"10.1152\/ajpregu.90650.2008","volume":"295","author":"N Tian","year":"2008","unstructured":"Tian N, Moore RS, Phillips WE, Lin L, Braddy S, Pryor JS, et al. NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am J Physiol-Regul Integ Comp Physiol 2008; 295: R1858\u201365.","journal-title":"Am J Physiol-Regul Integ Comp Physiol"},{"key":"BFaps2012164_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/1470320310391330","volume":"12","author":"MA Bayorh","year":"2011","unstructured":"Bayorh MA, Rollins-Hairston A, Adiyiah J, Lyn D, Eatman D . Eplerenone suppresses aldosterone\/salt-induced expression of NOX-4. J Renin Angiotensin Aldosterone Syst 2011; 12: 195\u2013201.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"BFaps2012164_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1023\/A:1011119003788","volume":"15","author":"B Pitt","year":"2001","unstructured":"Pitt B, Williams G, Remme W, Martinez F, Lopez-Sendon J, Zannad F, et al. The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Cardiovasc Drugs Ther 2001; 15: 79\u201387.","journal-title":"Cardiovasc Drugs Ther"},{"key":"BFaps2012164_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. New Engl J Med 2011; 364: 11\u201321.","journal-title":"New Engl J Med"},{"key":"BFaps2012164_CR14","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1161\/01.RES.0000146676.04359.64","volume":"95","author":"L Gao","year":"2004","unstructured":"Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, et al. Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ Res 2004; 95: 937\u201344.","journal-title":"Circ Res"},{"key":"BFaps2012164_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/10641960701500398","volume":"29","author":"AT Baumer","year":"2007","unstructured":"Baumer AT, Kruger CA, Falkenberg J, Freyhaus HT, Rosen R, Fink K, et al. The NAD(P)H oxidase inhibitor apocynin improves endothelial NO\/superoxide balance and lowers effectively blood pressure in spontaneously hypertensive rats: comparison to calcium channel blockade. Clin Exp Hypertens 2007; 29: 287\u201399.","journal-title":"Clin Exp Hypertens"},{"key":"BFaps2012164_CR16","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.amjhyper.2005.02.017","volume":"18","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Chan MM, Andrews MC, Mori TA, Croft KD, McKenzie KU, et al. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone\u2013induced hypertension in the rat. Am J Hypertens 2005; 18: 910\u20136.","journal-title":"Am J Hypertens"},{"key":"BFaps2012164_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1161\/HYPERTENSIONAHA.107.095315","volume":"50","author":"E Yamamoto","year":"2007","unstructured":"Yamamoto E, Kataoka K, Yamashita T, Tokutomi Y, Dong YF, Matsuba S, et al. Role of xanthine oxidoreductase in the reversal of diastolic heart failure by candesartan in the salt-sensitive hypertensive rat. Hypertension 2007; 50: 657\u201362.","journal-title":"Hypertension"},{"key":"BFaps2012164_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/jcp.1104","volume":"188","author":"Z Xie","year":"2001","unstructured":"Xie Z, Pimental DR, Lohan S, Vasertriger A, Pligavko C, Colucci WS, et al. Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: role of p42\/44 mitogen-activated protein kinase and reactive oxygen species. J Cellular Physiol 2001; 188: 132\u20138.","journal-title":"J Cellular Physiol"},{"key":"BFaps2012164_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1464-410X.2009.08374.x","volume":"104","author":"T Umekawa","year":"2009","unstructured":"Umekawa T, Tsuji H, Uemura H, Khan SR . Superoxide from NADPH oxidase as second messenger for the expression of osteopontin and monocyte chemoattractant protein-1 in renal epithelial cells exposed to calcium oxalate crystals. BJU Int 2009; 104: 115\u201320.","journal-title":"BJU Int"},{"key":"BFaps2012164_CR20","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1161\/01.RES.0000227550.00426.60","volume":"98","author":"CF Lai","year":"2006","unstructured":"Lai CF, Seshadri V, Huang K, Shao JS, Cai J, Vattikuti R, et al. An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells. Circ Res 2006; 98: 1479\u201389.","journal-title":"Circ Res"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2012164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2012164","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2012164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:27:40Z","timestamp":1684412860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2012164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,21]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["BFaps2012164"],"URL":"https:\/\/doi.org\/10.1038\/aps.2012.164","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,21]]}}}